Switch to:
More From Other Websites
GSK's new CEO aims to divest sports nutrition brand: sources Jun 22 2017
Glaxo's (GSK) Shingles Candidate Phase III Data Positive Jun 22 2017
Early movers: ORCL, HAIN, ACN, SCS, ATUS, NVS, GSK & more Jun 22 2017
GSK wins $235 million from Teva in Coreg patent trial Jun 21 2017
Amgen An Undervalued Industry Leader Jun 21 2017
GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine... Jun 21 2017
Dupixent May Prove Effective in Multiple Diseases Jun 20 2017
Label Expansion May Boost Regeneron’s Dupixent in the Future Jun 20 2017
Novartis (NVS) Biosimilar of MabThera Approved in the EU Jun 19 2017
GSK's new pharma head to join in September after AstraZeneca tussle Jun 19 2017
GlaxoSmithKline's Benlysta Positive in Continuation Trial Jun 19 2017
5 Answers to Questions Gilead Sciences' Investors Probably Have Jun 18 2017
Should Value Investors Pick GlaxoSmithKline (GSK) Stock Now? Jun 16 2017
Why GlaxoSmithKline Stock Had a Breakout May Jun 09 2017
Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma Jun 09 2017
Inovio's HPV Immunotherapy Moves to Phase III, Stock Rises Jun 09 2017
2 High-Yield Dividend Stocks That Might Be Incredible Bargains Right Now Jun 07 2017
Novartis, Bristol-Myers Collaborate for Opdivo Combination Jun 06 2017
2 giant drugmakers are racing to make a breakthrough in treating HIV, and there's $22 billion on the... Jun 06 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK